Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.36 USD | -10.16% |
|
-7.69% | +3.70% |
10/06 | William Blair Starts Tenaya Therapeutics With Outperform Rating | MT |
16/05 | Canaccord Genuity Adjusts Tenaya Therapeutics Price Target to $16 From $18, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.70% | 264M | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- TNYA Stock
- News Tenaya Therapeutics, Inc.
- Tenaya Therapeutics Q4 Loss Narrows